文献速递功能神经外科

杏仁核海马切开术治疗内侧颞叶硬化:术后5年癫痫结局

Amygdalohippocampotomy for mesial temporal lobe sclerosis: Epilepsy outcome 5 years after surgery.
PubMed 文献 · Acta Neurochir (Wien) · 2017-08-29

本研究评估内侧颞叶硬化(MTLS)患者接受杏仁核海马切开术(AHCo)的长期癫痫结局。自2007年起35例患者接受AHCo,其中21例随访超过5年(5至7.5年,平均6.5年)。术后5年Engel IA-B级15例(71.4%)、II级3例(14.3%),良好/非常好合计18例(85.7%);作者认为AHCo长期有效且可能比杏仁核海马切除术(AHC)更安全。

要点

  • AHCo术后5年良好/非常好结局为85.7%(18/21),其中Engel IA-B级71.4%(15/21)。
  • AHC长期结果为Engel I级87%、II级8%、III-IV级5%,AHCo与之无明显差异。
  • AHCo术后并发症包括偏瘫1例、言语记忆恶化2例、象限盲2例、迟发性抑郁3例。

核心结论

  • AHCo术后5年良好/非常好结果为86%,与AHC结果无明显差异。
  • 作者认为AHCo在长期随访中似乎有效且可能比AHC更安全。

研究设计与样本

  • 自2007年起35例患者(22例女性)接受AHCo,年龄20-61岁(平均42岁),左侧17例、右侧18例。
  • 其中21例(14例女性)随访超过5年(5至7.5年,平均6.5年),左侧11例、右侧10例。
  • 将本次结果与术后短期结果及接受AHC的患者进行比较。

主要发现

  • 21例中组织学确诊内侧颞叶硬化20例。
  • 术后5年Engel IA-B级15例(71.4%)、II级3例(14.3%),良好/非常好合计18例(85.7%)。
  • Engel III级2例(9.5%)、IV级1例(4.8%),不良合计3例。
  • 并发症:偏瘫1例(术后24小时高血压性囊性出血)、言语记忆恶化2例、象限盲2例、迟发性抑郁3例(药物治疗后逆转)。
  • AHC长期结果:Engel I级87%、II级8%、III-IV级5%,并发症同样少。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The goal of the present study is the evaluation of the long-term clinical outcome of epilepsy in patients with mesial temporal lobe sclerosis (MTLS) submitted to amygdalohippocampotomy (AHCo). AHCo consists of the lateral ablation of the amygdala and the peri-hippocampal disconnection instead of amygdalohippocampectomy (AHC), which involves the removal of both structures. We previously reported the short-term results of AHCo, so we here present the long-term results (> 5 years of follow-up) of the patients operated on with AHCo. METHOD: Since 2007, 35 patients (22 females) aged 20-61 years (mean: 42 years) were operated on with the AHCo technique, 17 patients on the left side and 18 on the right. Of these patients, 21 (14 females) have been followed up > 5 years (5 to 7.5 years, mean 6.5 years). We compare the present results with those observed shortly after surgery and with the patients operated on with AHC. FINDINGS: In all 21 cases, the diagnosis was mesial temporal lobe sclerosis (histology confirmed in 20), 11 on the left side and 10 on the right. Epilepsy results after 5 years were good/very good in 18 patients (85.7%), with Engel class IA-B in 15 (71.4%) and II in 3 (14.3%), and bad in 3 patients, with Engel Class III in 2 (9.5%) and class IV in 1 (4.8%). Concerning morbidity, one patient had hemiparesis (hypertensive capsular hemorrhage 24 h after surgery), two verbal memory worsening, two quadrantanopia and three late depression that was reversed with medication. Comparatively, the AHC long-term results were 87% Engel class I, 8% Engel class II and 5% Engel class III-IV. The morbidity was equally small. CONCLUSIONS: The good/very good results of AHCo 5 years after surgery are 86%, which is not distinct from the AHC results. So AHCo seems to be effective and potentially safer than AHC in long-term follow-up.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Gonçalves-Ferreira A, Rainha-Campos A, Franco A, et al. Amygdalohippocampotomy for mesial temporal lobe sclerosis: Epilepsy outcome 5 years after surgery. Acta Neurochir (Wien). 2017. PMID: 28849383. doi:10.1007/s00701-017-3305-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。